Hyloris Pharmaceuticals SA
XBRU:HYL

Watchlist Manager
Hyloris Pharmaceuticals SA Logo
Hyloris Pharmaceuticals SA
XBRU:HYL
Watchlist
Price: 5.74 EUR -1.03% Market Closed
Market Cap: 160.7m EUR
Have any thoughts about
Hyloris Pharmaceuticals SA?
Write Note

Hyloris Pharmaceuticals SA
Other Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Hyloris Pharmaceuticals SA
Other Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Hyloris Pharmaceuticals SA
XBRU:HYL
Other Receivables
€244k
CAGR 3-Years
N/A
CAGR 5-Years
-24%
CAGR 10-Years
N/A
Ucb SA
XBRU:UCB
Other Receivables
€379m
CAGR 3-Years
26%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Financiere de Tubize SA
XBRU:TUB
Other Receivables
€0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Hyloris Pharmaceuticals SA
Glance View

Market Cap
160.7m EUR
Industry
Pharmaceuticals

Hyloris Pharmaceuticals SA engages in the development and reformulating of pharmaceutical products. The company is headquartered in Liege, Liege and currently employs 14 full-time employees. The company went IPO on 2020-06-29. Its focus is on re-engineering cardiovascular products. Additionally, it also further develops and improves already-approved pharmaceuticals and established products, creating new and different solutions. The Company’s diverse product-development portfolio spans a wide range of therapeutic indications and dosage forms.

HYL Intrinsic Value
4.38 EUR
Overvaluation 24%
Intrinsic Value
Price

See Also

What is Hyloris Pharmaceuticals SA's Other Receivables?
Other Receivables
244k EUR

Based on the financial report for Dec 31, 2023, Hyloris Pharmaceuticals SA's Other Receivables amounts to 244k EUR.

What is Hyloris Pharmaceuticals SA's Other Receivables growth rate?
Other Receivables CAGR 5Y
-24%

Back to Top